Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets

Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are intimately associated with inflammation and overproduction of reactive oxygen species (ROS). Temporal and inter-individual variabilities in disease activity and response to therapy pose signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourgonje, Arno R., Kloska, Damian, Grochot-Przęczek, Anna, Feelisch, Martin, Cuadrado, Antonio, van Goor, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841059/
https://www.ncbi.nlm.nih.gov/pubmed/36634466
http://dx.doi.org/10.1016/j.redox.2023.102603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841059/
https://www.ncbi.nlm.nih.gov/pubmed/36634466
http://dx.doi.org/10.1016/j.redox.2023.102603

Ejemplares similares